India, Aug. 7 -- PharmEasy founder Siddharth Shah has stepped down as the chief executive officer of the company. He will assume the roles of director and vice chairman at PharmEasy's parent entity, API Holdings.
Thyrocare's managing director and chief executive Rahul Guha will succeed Shah as PharmEasy CEO, effective August 21. In 2021, API Holdings acquired a 66.1% stake in Thyrocare for INR 4,546 Cr.
Thyrocare said in a statement that the decision was made on the recommendation of the nomination and remuneration committee of API Holdings and was subsequently approved by its board.
According to his LinkedIn profile, Shah has been the chief executive of API Holdings since 2020. Besides, he also cofounded a host of healthcare ventures ...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.